In the past week, HOLX stock has gone down by -4.21%, with a monthly decline of -1.05% and a quarterly surge of 3.05%. The volatility ratio for the week is 1.85%, and the volatility levels for the last 30 days are 1.57% for Hologic, Inc.. The simple moving average for the past 20 days is -2.24% for HOLX’s stock, with a 2.21% simple moving average for the past 200 days.
Is It Worth Investing in Hologic, Inc. (NASDAQ: HOLX) Right Now?
The price-to-earnings ratio for Hologic, Inc. (NASDAQ: HOLX) is above average at 35.71x, Company’s 36-month beta value is 1.01.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for HOLX is 231.12M, and currently, short sellers hold a 1.92% ratio of that floaft. The average trading volume of HOLX on April 17, 2024 was 1.77M shares.
HOLX) stock’s latest price update
The stock of Hologic, Inc. (NASDAQ: HOLX) has decreased by -3.13 when compared to last closing price of 77.54.Despite this, the company has seen a loss of -4.21% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-15 that Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.
Analysts’ Opinion of HOLX
Many brokerage firms have already submitted their reports for HOLX stocks, with Citigroup repeating the rating for HOLX by listing it as a “Buy.” The predicted price for HOLX in the upcoming period, according to Citigroup is $95 based on the research report published on April 03, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $95. The rating they have provided for HOLX stocks is “Buy” according to the report published on July 14th, 2023.
RBC Capital Mkts gave a rating of “Sector Perform” to HOLX, setting the target price at $75 in the report published on December 07th of the previous year.
HOLX Trading at -0.51% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.53% of loss for the given period.
Volatility was left at 1.57%, however, over the last 30 days, the volatility rate increased by 1.85%, as shares sank -1.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.69% upper at present.
During the last 5 trading sessions, HOLX fell by -4.21%, which changed the moving average for the period of 200-days by -6.19% in comparison to the 20-day moving average, which settled at $76.77. In addition, Hologic, Inc. saw 5.12% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from GARRETT SCOTT T, who sale 16,441 shares at the price of $75.50 back on Mar 14 ’24. After this action, GARRETT SCOTT T now owns 48,611 shares of Hologic, Inc., valued at $1,241,296 using the latest closing price.
CRAWFORD SALLY, the Director of Hologic, Inc., sale 9,039 shares at $76.40 during a trade that took place back on Mar 08 ’24, which means that CRAWFORD SALLY is holding 132,927 shares at $690,607 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.69 for the gross margin
The net margin for Hologic, Inc. stands at 0.13. The total capital return value is set at 0.08. Equity return is now at value 10.57, with 5.80 for asset returns.
Based on Hologic, Inc. (HOLX), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.39. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 10.6.
Currently, EBITDA for the company is 1.2 billion with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of 4.6. The receivables turnover for the company is 5.92for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.89.
Conclusion
In a nutshell, Hologic, Inc. (HOLX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
